These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20711088)

  • 1. Oral contraceptives and systemic lupus erythematosus: what should we advise to our patients?
    Duarte C; Inês L
    Acta Reumatol Port; 2010; 35(2):133-40. PubMed ID: 20711088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogen antibodies, oral contraception and systemic lupus erythematosus.
    Beaumont V; Gioud-Paquet M; Kahn MF; Beaumont JL
    Clin Physiol Biochem; 1989; 7(5):263-8. PubMed ID: 2805575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of exogenous estrogens in systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    Semin Arthritis Rheum; 2001 Jun; 30(6):426-35. PubMed ID: 11404826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of hormonal contraception on the course of lupus nephropathy].
    Jungers P; Dougados M; Pélissier C; Kuttenn F; Tron F; Pertuiset N; Bach JF
    Nouv Presse Med; 1982 Dec; 11(51):3765-8. PubMed ID: 7155880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic assessment of the risks of oral contraception.
    Petitti DB
    J Reprod Med; 1986 Sep; 31(9 Suppl):887-91. PubMed ID: 3772908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive therapy and systemic lupus erythematosus.
    Travers RL; Hughes GR
    J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
    Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contraception in women suffering from systemic lupus ethymatosus].
    Musson P; Serfaty D; Puissant A
    Contracept Fertil Sex (Paris); 1985 Oct; 13(10):1063-7. PubMed ID: 12267711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contraception in adolescents with systemic lupus erythematosus.
    Tincani A; Nuzzo M; Lojacono A; Cattalini M; Meini A
    Lupus; 2007; 16(8):600-5. PubMed ID: 17711895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives in women with systemic lupus erythematosus.
    Buyon JP
    Ann Med Interne (Paris); 1996; 147(4):259-64. PubMed ID: 8952745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond contraception: the health benefits and risks of the pill.
    Escobedo L; Lee NC
    IPPF Med Bull; 1988 Apr; 22(2):1-2. PubMed ID: 12315433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of contraceptive methods in women with systemic lupus erythematosus.
    Sánchez-Guerrero J; Uribe AG; Jiménez-Santana L; Mestanza-Peralta M; Lara-Reyes P; Seuc AH; Cravioto MD
    N Engl J Med; 2005 Dec; 353(24):2539-49. PubMed ID: 16354890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous effects in hormonal contraception].
    Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
    NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG
    Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical aspects of contraception.
    Goldzieher JW; Poindexter AN
    Hosp Pract (Off Ed); 1987 Mar; 22(3A):93-6, 99-101, 105 passim. PubMed ID: 3102532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depot medroxyprogesterone acetate contraception in women with medical problems.
    Frederiksen MC
    J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.